Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
MLTX.OQ - MoonLake Immunotherapeutics
MoonLake Immunotherapeutics Investor Day
Feb 23, 2026 / 01:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning. Good afternoon.
Thank you so much for joining our investor day today at Moon Lake Immunotherapeutics. My name is Matthias Boldenstadt. I'm the CFO of the company and I'm sitting here on the right, Dr.
George Santos da Silva, our Chief Executive Officer.
And Professor Christian Reich, our Chief Scientific Officer.
Together, we are very excited to walk you through a number of, updates about the company. I will start with a very brief introduction. Then Christian will present our phase two data from the Solaris study in axial spondyloarthritis.
After that, will provide an update on the hidradenitis suppurativa front.
He will, on the one hand summarize the
Trustpilot
